8-K: Purple Innovation Reports Q2 Revenue Decline and Increased Net Loss Amidst Strong New Product Demand

Purple Innovation, Inc. announced its second quarter 2025 financial results, reporting a 12.6% decline in net revenue and a significant net loss, despite an improvement in Adjusted EBITDA and strong demand for its new Rejuvenate 2.0 collection.

Summary

• Net revenue for the second quarter of 2025 decreased by 12.6% to $105.1 million, down from $120.3 million in Q2 2024.
• Gross profit for the second quarter was $37.7 million, a decrease from $48.9 million in the prior-year period, resulting in a gross margin of 35.9%, down 480 basis points year-over-year.
• Net loss attributable to Purple Innovation, Inc. for the second quarter was $(17.3) million, a decline from $0.0 million in the prior year.
• Adjusted EBITDA for the second quarter improved to $(2.4) million, compared to $(4.1) million in the same period last year.
• Operating expenses decreased by 18.2% to $51.9 million, primarily due to reduced advertising spend and benefits from prior restructuring and cost savings initiatives.
• Cash and cash equivalents stood at $34.2 million as of June 30, 2025, an increase from $29.0 million at December 31, 2024.
• Net inventories totaled $60.9 million as of June 30, 2025, down 12.6% compared to June 30, 2024, but up 7.1% compared to December 31, 2024.
• The company reiterated its full-year 2025 outlook, projecting revenue in the range of $465 million to $485 million and adjusted EBITDA in the range of flat to positive $10 million.
• Third quarter revenue-to-date is up in the mid-single digits range compared to the same period last year.

Sentiment

Score: 4

Explanation: The sentiment is mixed to slightly negative. While there are positives like improved Adjusted EBITDA, reduced operating expenses, strong new product demand, and positive Q3-to-date revenue, these are overshadowed by a significant decline in net revenue, a substantial increase in net loss, and a decrease in gross margin. The increase in related party debt and warrant liabilities also adds a layer of concern. The company's reiteration of guidance and strategic initiatives provide some stability, but the Q2 performance itself is weak.

Positives

• Adjusted EBITDA improved to $(2.4) million in Q2 2025 from $(4.1) million in Q2 2024, driven by disciplined cost management.
• Operating expenses decreased by 18.2% to $51.9 million, largely due to reduced advertising spend and benefits from restructuring and cost savings initiatives.
• Strong demand for the new Rejuvenate 2.0 collection, with demand more than double the Rejuvenate 1.0 launch in Direct-to-Consumer (DTC) channels.
• The Mattress Firm rollout is progressing on schedule, building significant momentum.
• Deepening relationships with partners such as Walmart and Costco, and growing interest from both traditional and non-traditional partners.
• Third quarter revenue-to-date is up in the mid-single digits range versus the same period last year, indicating sequential growth.
• Cash and cash equivalents increased to $34.2 million as of June 30, 2025, from $29.0 million at December 31, 2024.

Negatives

• Net revenue declined by 12.6% to $105.1 million in Q2 2025 compared to $120.3 million in Q2 2024.
• Net loss attributable to Purple Innovation, Inc. was $(17.3) million in Q2 2025, a significant decline from $0.0 million in Q2 2024.
• Gross margin decreased by 480 basis points year-over-year to 35.9%, adversely impacted by tariffs and ramp-up costs for the Mattress Firm rollout and Rejuvenate 2.0 launch.
• Revenue decline was attributed to delays in Rejuvenate 2.0 shipments, lapping reductions in wholesale door count from 2024, and softness in ecommerce.
• Related party debt increased significantly to $94.539 million as of June 30, 2025, from $55.394 million at December 31, 2024.
• Warrant liabilities increased to $28.925 million as of June 30, 2025, from $16.067 million at December 31, 2024.

Risks

• Changes in economic, financial, and end-market conditions in the markets where the company operates.
• Fluctuations in raw material prices and cost of labor.
• The financial condition of the company's customers and suppliers.
• Competitive pressures, including the need for technology improvement, successful new product development, and introduction.
• Changes in consumer demand, including potential pullbacks in consumer spending.
• Disruptions to the company's manufacturing processes.
• Other risk factors outlined in the Risk Factors section of the company's Annual Report on Form 10-K filed with the SEC on March 14, 2025, and in other SEC filings.

Future Outlook

The company is reiterating its 2025 outlook for full year revenue to be in the range of $465 million to $485 million and adjusted EBITDA in the range of flat to positive $10 million. Management anticipates sequential growth in the second half of the year, driven by the successful launch of Rejuvenate 2.0 and the ongoing rollout of its expanded partnership with Mattress Firm. Third quarter revenue-to-date is already showing mid-single digit growth compared to the same period last year, reinforcing confidence in driving profitable growth and creating shareholder value.

Management Comments

• "We are pleased with our second quarter performance, which reflects our disciplined execution and continued progress as we build a premium, sustainable, and profitable brand."
• "Revenue and profit exceeded our expectations, delivering sequential improvement, where strong demand from consumers and partners has temporarily outpaced our ability to fulfill orders."
• "We are seeing strong validation of our brand and innovation strategy, led by the breakthrough success of our Rejuvenate 2.0 collection -the first product to incorporate our new DreamLayer grid technology layered on top of our core GelFlex grid platform."
• "We're also building significant momentum through our ongoing expansion with Mattress Firm, which remains on track, and through deepening relationships with partners such as Walmart and Costco, alongside strong and growing interest from both traditional and non-traditional partners."
• "These initiatives are fueling momentum across our business and advancing our long-term Path to Premium Sleep strategy."
• "With third quarter revenue-to-date up in the mid-single digits range versus the same period last year, we remain confident in our ability to drive profitable growth and create shareholder value."

Industry Context

The mattress and sleep technology industry continues to evolve with a focus on innovation and direct-to-consumer models, alongside traditional retail partnerships. Purple Innovation's emphasis on its patented GelFlex Grid technology and new product lines like Rejuvenate 2.0 aligns with the industry trend towards advanced materials and personalized comfort solutions. The expansion with Mattress Firm and deepening relationships with major retailers like Walmart and Costco reflect a hybrid strategy to capture market share across various channels, a common approach in the competitive home furnishings sector. The reported softness in e-commerce could indicate a broader shift in consumer spending patterns or increased competition in online channels within the industry.

Comparison to Industry Standards

• The decline in net revenue by 12.6% contrasts with some industry players who have managed to maintain or grow revenue, albeit in a challenging economic environment. For example, while specific comparable companies are not named in the filing, the broader home goods and mattress sector has seen mixed performance, with some premium brands demonstrating resilience.
• The improvement in Adjusted EBITDA from a larger negative to a smaller negative indicates progress in cost management, which is a positive sign in an industry often characterized by high marketing and operational costs. This suggests the company is becoming more efficient relative to its peers who may still be struggling with profitability.
• The strong demand for the Rejuvenate 2.0 collection, exceeding the launch performance of its predecessor, suggests that product innovation remains a key differentiator and a potential driver of future growth, a strategy often employed by market leaders like Tempur Sealy or Serta Simmons Bedding to capture premium segments.
• The ongoing rollout with Mattress Firm, a major national retailer, positions Purple to expand its physical footprint significantly, a strategy that has proven successful for established brands seeking broader market penetration beyond online sales.

Related Party Transactions

• Related party debt increased to $94.539 million as of June 30, 2025, from $55.394 million as of December 31, 2024.

Stakeholder Impact

• Shareholders: Experienced a significant net loss and revenue decline, potentially impacting stock performance, though Adjusted EBITDA improved and future guidance was reiterated.
• Customers: Strong demand for new products like Rejuvenate 2.0 indicates positive reception, but shipment delays could impact customer satisfaction.
• Employees: Benefits from restructuring and cost savings initiatives were mentioned, implying past workforce adjustments.
• Suppliers: Gross margin was adversely impacted by tariffs and ramp-up costs, which could affect supplier relationships or sourcing strategies.
• Creditors: The substantial increase in related party debt indicates increased leverage and reliance on specific financing sources.

Next Steps

• Continue the successful launch and fulfillment of the Rejuvenate 2.0 collection.
• Proceed with the ongoing expansion and rollout of products through the partnership with Mattress Firm.
• Further deepen relationships with partners such as Walmart and Costco.
• Drive sequential growth in the second half of 2025 to meet full-year revenue and Adjusted EBITDA guidance.
• Host a live conference call on July 29, 2025, at 4:30 p.m. Eastern Time to discuss financial results.

Key Dates

Recommendation

The Q2 results present a mixed picture. While the company saw a significant decline in revenue and a substantial net loss, the improvement in Adjusted EBITDA and the reduction in operating expenses demonstrate effective cost management. The strong demand for the new Rejuvenate 2.0 product line and the progress with the Mattress Firm rollout are positive strategic indicators for future growth. However, the increase in related party debt and warrant liabilities adds a layer of financial risk. The reiteration of full-year guidance, supported by positive Q3-to-date revenue, suggests management believes in a strong second half recovery. Given the contradictory signals – poor current quarter performance offset by strategic progress and optimistic forward guidance – a 'hold' recommendation is appropriate. Investors should monitor the execution of the Mattress Firm rollout and the sustained demand for new products, as well as the company's ability to manage its debt and achieve its full-year profitability targets.

Keywords

Mattress, Sleep Technology, GelFlex Grid, Comfort Innovation, Home Furnishings, E-commerce, Wholesale, Financial Results, Adjusted EBITDA, Revenue, Net Loss, Rejuvenate 2.0, Mattress Firm, Retail Partnerships